Artery Research
Volume 1, Issue 1 , Pages 20-25 , June 2007

Sodium excretion as a modulator of genetic influence on arterial stiffness and other cardiovascular phenotypes

  • Katarzyna Stolarz

      Affiliations

    • First Department of Cardiology and Hypertension, Medical College, Jagiellonian University, Kopernika 17, 31-501, Cracow, Poland
    • Corresponding Author InformationCorresponding author. Tel.: +48 12 424 73 00; fax: +48 12 424 73 20.
    • ,
  • Tatiana Kuznetsova

      Affiliations

    • Study Coordinating Centre, Hypertension and Cardiovascular Rehabilitation Unit, Department of Molecular and Cardiovascular Research, University of Leuven, Leuven, Belgium
    • Institute of Internal Medicine, Novosibirsk, Russian Federation
    • ,
  • Wiktoria Wojciechowska

      Affiliations

    • First Department of Cardiology and Hypertension, Medical College, Jagiellonian University, Kopernika 17, 31-501, Cracow, Poland
    • ,
  • Jitka Seidlerova

      Affiliations

    • Charles University, Pilsen, Czech Republic
    • ,
  • Edoardo Casiglia

      Affiliations

    • Department of Clinical and Experimental Medicine, University of Padova, Italy
    • ,
  • Jan Filipovský

      Affiliations

    • Charles University, Pilsen, Czech Republic
    • ,
  • Jan Peleška

      Affiliations

    • General Faculty Hospital, Prague, Czech Republic
    • ,
  • Yuri Nikitin

      Affiliations

    • Institute of Internal Medicine, Novosibirsk, Russian Federation
    • ,
  • Jan A. Staessen

      Affiliations

    • Study Coordinating Centre, Hypertension and Cardiovascular Rehabilitation Unit, Department of Molecular and Cardiovascular Research, University of Leuven, Leuven, Belgium
    • ,
  • Kalina Kawecka-Jaszcz

      Affiliations

    • First Department of Cardiology and Hypertension, Medical College, Jagiellonian University, Kopernika 17, 31-501, Cracow, Poland
    • ,
  • on behalf of the European Project On Genes in Hypertension (EPOGH) Investigators

References 

  1. Bronner LL, Kanter DS, Manson JE. Primary prevention of stroke. N Engl J Med. 1995;333:1392–1400
  2. Staessen JA, Wang JG, Birkenhäger WH. Outcome beyond blood pressure control?. Eur Heart J. 2003;24:504–514
  3. Staessen JA, Wang J, Bianchi G, Birkenhäger WH. Essential hypertension. Lancet. 2003;361:1629–1641
  4. Matsukawa T, Ichikawa I. Biological functions of angiotensin and its receptors. Annu Rev Physiol. 1997;59:395–412
  5. Ferrandi M, Salardi S, Tripodi G, Barassi P, Rivera R, Manunta P, et al. Evidence for an interaction between adducin and Na+–K+-ATPase: relation to genetic hypertension. Am J Physiol. 1999;277:H1338–H1349
  6. O'Shaughnessy KM, Karet FE. Salt handling and hypertension. J Clin Invest. 2004;113:1075–1081
  7. Schmieder RE, Messerli FH, Garavaglia GE, Nunez BD. Dietary salt intake. A determinant of cardiac involvement in essential hypertension. Circulation. 1988;78:951–956
  8. Safar ME, Thuilliez C, Richard V, Benetos A. Pressure-independent contribution of sodium to large artery structure and function in hypertension. Cardiovasc Res. 2000;46:269–276
  9. Wojciechowska W, Staessen JA, Stolarz K, Nawrot T, Filipovsky J, Ticha M, et al. Association of peripheral and central arterial wave reflections with the CYP11B2 −344C allele and sodium excretion. J Hypertens. 2004;22:2311–2319
  10. Takeda Y. Pathophysiological roles of vascular 11 beta-hydroxysteroid dehydrogenase and aldosterone. J Steroid Biochem Mol Biol. 2003;85:443–447
  11. Seidlerova J, Staessen JA, Maillard M, Nawrot T, Zhang H, Bochud M, et al. Association between arterial properties and renal sodium handling in a general population. Hypertension. 2006;48:609–615
  12. Dzau VJ. Tissue renin–angiotensin system in myocardial hypertrophy and failure. Arch Intern Med. 1993;153:937–942
  13. Kuznetsova T, Staessen JA, Stolarz K, Ryabikov A, Tikhonoff V, Olszanecka A, et al. Relationship of left ventricular mass and the ACE D/I polymorphism varies according to sodium intake. J Hypertens. 2004;22:287–295
  14. Kuznetsova T, Staessen JA, Thijs L, Kunath C, Olszanecka A, Ryabikov A, et al. Left ventricular mass in relation to genetic variation in angiotensin II receptors, renin system genes, and sodium excretion. Circulation. 2004;110:2644–2650
  15. Kuznetsova T, Staessen JA, Wang JG, Gasowski J, Nikitin Y, Ryabikov A, et al. Antihypertensive treatment modulates the association between the D/I ACE gene polymorphism and left ventricular hypertrophy: a meta-analysis. J Hum Hypertens. 2000;14:447–454
  16. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343–1346
  17. Hiraga H, Oshima T, Watanabe M, Ishida M, Ishida T, Shingu T, et al. Angiotensin I-converting enzyme gene polymorphism and salt sensitivity in essential hypertension. Hypertension. 1996;27(Pt 2):569–572
  18. Poch E, González D, Giner V, Bragulat E, Coca A, de la Sierra A. Molecular basis for salt sensitivity in human hypertension. Evaluation of the renin–angiotensin–aldosterone system gene polymorphisms. Hypertension. 2001;38:1204–1209
  19. Schmieder RE, Langenfeld MRW, Friedrich A, Schobel HP, Gatzka CD, Weihprecht H. Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension. Circulation. 1996;94:1304–1309
  20. Duncan AM, Scholey JW, Miller JA. Angiotensin II type 1 receptor gene polymorphisms in humans: physiology and pathophysiology of the genotypes. Curr Opin Nephrol Hypertens. 2001;10:111–116
  21. Castellano M, Muiesan ML, Beschi M, Rizzoni D, Cinelli A, Salvetti M, et al. Angiotensin II type 1 receptor A/C1166 polymorphism. Relationships with blood pressure and cardiovascular structure. Hypertension. 1996;28:1076–1080
  22. Hamon M, Amant C, Bauters C, Richard F, Helbecque N, McFadden E, et al. Association of angiotensin converting enzyme and angiotensin II type 1 receptor genotypes with left ventricular function and mass in patients with angiographically normal coronary arteries. Heart. 1997;77:502–505
  23. Takami S, Katsuya T, Rakugi H, Sato N, Nakata Y, Kamitani A, et al. Angiotensin II type 1 receptor gene polymorphism is associated with increase of left ventricular mass but not with hypertension. Am J Hypertens. 1998;11:316–321
  24. De Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International Union of Pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev. 2000;52:415–472
  25. Warnecke C, Willich T, Holzmeister J, Bottari SP, Fleck E, Regitz-Zagrosek V. Efficient transcription of the human angiotensin II type 2 receptor gene requires intronic sequence elements. Biochem J. 1999;340:17–24
  26. Schmieder RE, Erdmann J, Delles C, Jacobi J, Fleck E, Hilgers K, et al. Effect of the angiotensin II type 2-receptor gene (+1675 G/A) on left ventricular structure in humans. J Am Coll Cardiol. 2001;37:175–182
  27. Herrmann SM, Nicaud V, Schmidt-Petersen K, Pfeifer J, Erdmann J, McDonagh T, et al. Angiotensin II type 2 receptor gene polymorphism and cardiovascular phenotypes: the GLAECO and GLAOLD studies. Eur J Heart Failure. 2002;4:707–712
  28. Ozono R, Wang ZQ, Moore AF, Inagami T, Siragy HM, Carey RM. Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension. 1997;30:1238–1246
  29. Siragy HM, Inagami T, Ichiki T, Carey RM. Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci U S A. 1999;96:6506–6510
  30. Huang Y, Wang DH. Role of AT1 and AT2 receptor subtypes in salt-sensitive hypertension induced by sensory nerve degeneration. J Hypertens. 2001;19:1841–1846
  31. DiBona GF. Nervous kidney. Interaction between renal sympathetic nerves and the renin–angiotensin system in the control of renal function. Hypertension. 2000;36:1083–1088
  32. Stolarz K, Staessen JA, Kawecka-Jaszcz K, Brand E, Bianchi G, Kuznetsova T, et al. Genetic variation in CYP11B2 and ATR1 influences heart rate variability conditional on sodium excretion. Hypertension. 2004;44:156–162
  33. Veglio F, Melchio R, Rabbia F, Molino P, Martini G, Chiandussi L. Spectral characteristics of heart rate and blood pressure variability in primary aldosteronism. Am J Hypertens. 1995;8:479–486
  34. Spinelli L, Petretta M, Marciano F, Testa G, Rao MA, Volpe M, et al. Cardiac autonomic responses to volume overload in normal subjects and in patients with dilated cardiomyopathy. Am J Physiol. 1999;277:H1361–H1368
  35. Beretta-Piccoli C, Weidmann P, Brown JJ, Davies DL, Lever AF, Robertson JIS. Body sodium and blood volume state in essential hypertension: abnormal relation of exchangeable sodium to age and blood pressure in male patients. J Cardiovasc Pharmacol. 1984;6(Suppl. 1):S134–S142
  36. Strehlow K, Nickenig G, Roeling J, Wassmann S, Zolk O, Knorr A, et al. AT1 receptor regulation in salt-sensitive hypertension. Am J Physiol. 1999;277:H1701–H1707

PII: S1872-9312(07)00003-8

doi: 10.1016/j.artres.2007.03.002

Artery Research
Volume 1, Issue 1 , Pages 20-25 , June 2007

Article Tools

* Image Usage & Resolution